Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Anal Cancer Companies

ID: MRFR/MED/1001-HCR
130 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Several pharmaceutical and biotechnology companies are involved in the development of cancer therapies, including those targeting various types of cancers, such as anal cancer. Anal cancer is a relatively rare cancer that forms in the tissues of the anus. Treatments may include surgery, radiation therapy, and chemotherapy.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anal Cancer Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.72%
2024 Market Size$ 1.03 Billion
2025 Market Size$ 1.11 Billion
2035 Market Size$ 2.34 Billion
Key Players
Bristol-Myers Squibb
Merck & Co.
Amgen
Gilead Sciences
Eli Lilly and Company
AstraZeneca
Opportunities
  • Rising Incidence Rates
  • Innovative Treatment Options
  • Increased Screening and Early Detection

Top Industry Leaders in the Anal Cancer Market

Anal Cancer Companies
ย 

Latestย Anal Cancerย Companiesย Updates:

Oncolytics Biotech presented promising data at the ASH annual meeting regarding the combination of their drug pelareorep with the checkpoint inhibitor atezolizumab for advanced squamous cell carcinoma of the anus (SCCA). This could offer a new treatment option for this difficult-to-treat cancer.

Bristol Myers Squibb showcased several research findings on blood disorders and cell therapy at the ASH meeting, including potential advancements in immunotherapy for anal cancer.Virtu Market Research reported a projected value of USD 669.24 million for the Global Rapid Diagnostic Testing for Anal Cancer Market by 2030, indicating continued growth in demand for fast and accurate diagnosis.

List ofย Anal Cancerย Key companies in the market:

  • Amgen Inc. (US)
  • Bristol-Myers Squibb Company (US)
  • Celgene Corporation (US)
  • Eli Lilly and Company (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck & Co., Inc. (US)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Sanofi (France)